[ Price : $8.95]
Federal Register notice: FDA develops a list of drug products and categories of drug products that are difficult to compound.[ Price : $8.95]
Federal Register notice: CDRH announces a Software Precertification Pilot Program to evaluate a new approach for software products...[ Price : $8.95]
FDA announces a 9/13 public workshop on Developing a Framework for Regulatory Use of Real-World Evidence.[ Price : $8.95]
FDA issues a safety alert after it received recent adverse event reports about Guardian Pharmacy Services compounded triamicinolon...[ Price : $8.95]
Advanced Accelerator Applications resubmits an NDA for Lutathera (lutetium Lu 177 dotatate) for treating unresectable or metastati...[ Price : $8.95]
A Tennessee federal court enters a permanent injunction stopping Crown Laboratories from distributing unapproved and misbranded dr...[ Price : $8.95]
AstraZeneca and Merck announce a collaboration to develop and commercialize AstraZenecas cancer drug Lynparza.[ Price : $8.95]
Aradigm files an NDA for Linhaliq (liposomal ciprofloxacin for inhalation) for treating non-cystic fibrosis bronchiectasis patient...